Is Cardica, Inc. (CRDC) A Good Stock To Buy?

Earlier we told you that the aggregate hedge fund interest in the stock was unchanged and we view this as a negative development. Even though there weren’t any hedge funds dumping their holdings during the third quarter, there weren’t any hedge funds initiating brand new positions. This indicates that hedge funds, at the very best, perceive this stock as dead money and they haven’t identified any viable catalysts that can attract investor attention.

Let’s check out hedge fund activity in other stocks – not necessarily in the same industry as Cardica, Inc. (NASDAQ:CRDC) but similarly valued. These stocks are Ampliphi Biosciences Corp (NYSEMKT:APHB), Pacific Sunwear of California, Inc. (NASDAQ:PSUN), Paragon Offshore PLC (NYSE:PGN), and Amedica Corporation (NASDAQ:AMDA). All of these stocks’ market caps match Cardica, Inc. (NASDAQ:CRDC)’s market cap.

As you can see, these stocks had an average of 6 hedge funds with bullish positions and the average amount invested in these stocks was $2 million. That figure was $8 million in Cardica, Inc. (NASDAQ:CRDC)’s case. Paragon Offshore PLC (NYSE:PGN) is the most popular stock in this table, while Amedica Corporation (NASDAQ:AMDA) is the least popular one with only 4 bullish hedge fund positions. Cardica, Inc. (NASDAQ:CRDC) is not the least popular stock in this group, but hedge fund interest is still below average. This is a slightly negative signal and we’d rather spend our time researching stocks that hedge funds are piling on. In this regard, Paragon Offshore PLC (NYSE:PGN) might be a better candidate to consider a long position.